Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data

J Gen Intern Med. 2019 Sep;34(9):1682-1684. doi: 10.1007/s11606-019-04989-6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cost Savings / economics*
  • Cost Savings / trends
  • Data Analysis*
  • Drug Delivery Systems / economics*
  • Drug Delivery Systems / trends
  • Drugs, Generic / administration & dosage
  • Drugs, Generic / economics*
  • Epinephrine / administration & dosage
  • Epinephrine / economics*
  • Humans
  • Medicaid / economics*
  • Medicaid / trends
  • Retrospective Studies
  • United States / epidemiology

Substances

  • Drugs, Generic
  • Epinephrine